Steady-State Pharmacokinetics of Rivastigmine in Patients with Mild to Moderate Alzheimer's Disease Not Affected by Co-Administration of Memantine: An Open-Label, Crossover, Single-Centre Study

By Shua-Haim Joshua  

Clinical Drug Investigation, Vol. 28, Iss. 6, 2008-01 ,pp. : 361-374

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Cinacalcet in Hepatic Impairment: Phase I, Open-Label, Parallel-Group, Single-Dose, Single-Centre Study

By Padhi Desmond  

Clinical Drug Investigation, Vol. 28, Iss. 10, 2008-01 ,pp. : 635-643

Adis International

Access to resources Recommend Favorite

Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate: An Open-Label, Parallel-Group, Single-Centre Study

By Stangier Joachim  

Clinical Pharmacokinetics, Vol. 49, Iss. 4, 2010-04 ,pp. : 259-268

Adis International

Access to resources Recommend Favorite

Comparison of the Pharmacokinetics of Apricitabine in the Presence and Absence of Ritonavir-Boosted Tipranavir: A Phase I, Open-Label, Controlled, Single-Centre Study

By Cox Susan  

Clinical Drug Investigation, Vol. 29, Iss. 11, 2009-11 ,pp. : 721-728

Adis International

Access to resources Recommend Favorite

Candesartan Cilexetil in Haemodialysis Patients

By Ottosson P.  

Clinical Drug Investigation, Vol. 23, Iss. 8, 2003-01 ,pp. : 545-550

Adis International

Access to resources Recommend Favorite